According to the research report titled ‘Global Nasal Drug Delivery Technology Market Size study, By Dosage Form (Sprays, Drops & Liquids, Powders, Gels), By Container (Pressurized Containers, Non-pressurized Containers), By System (Multi-dose Systems, Bi-dose Systems, Unit-dose Systems), By Therapeutic Application (Allergic and Non-Allergic Rhinitis, Nose Congestion, Vaccination, Other Therapeutic Applications), By End-User (Home Care Settings, Hospitals), and Regional Forecasts 2022-2028’, available with MarketStudyReport, global nasal drug delivery technology market was valued at USD 60.28 billion in 2021 and is anticipated to reach USD 93.67 billion by 2028, witnessing over 6.5% CAGR during the forecast timeline.

The growing awareness of nasal drug delivery technologies and increasing inclination toward self-administration practices are some of the prime factors driving the expansion of global nasal drug delivery technology market.

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/5065410/  

For those unaware, nasal drug delivery technology is a method of providing the medication directly through the nasal route as well as allowing direct access to the circulatory system.

Aside from this, rising product developments, the growing prevalence of chronic diseases, mounting focus on alternative administration routes, and the increasing number of FDA approvals will add traction to global nasal drug delivery technology industry size. However, the excessive use of nasal sprays is likely to hinder the overall market growth.

Based on dosage form, the market is divided into gels, powders, drops & liquids, and sprays. Moving on to the container type, the industry is fragmented into non-pressurized and pressurized containers.

As per the system, the market is segmented into unit-dose, multi-dose, and bi-dose systems. In terms of therapeutic application, the industry is categorized into vaccination, nose congestion, non-allergic & allergic rhinitis, and other therapeutic applications.

With respect to the end-user spectrum, the market is divided into hospitals and home care settings.

Regionally, North America is expected to generate lucrative returns for the market contenders in the forthcoming years, owing to the rising consumer awareness of the availability of nasal products and the increasing prevalence of nasal-related diseases.

Whereas Asia Pacific nasal drug delivery technology market is projected to register the highest growth rate over the forecast period, primarily ascribed to easy accessibility to competent treatment methods and the presence of major companies.

The leading companies influencing the global nasal drug delivery technology market trends are 3M Company, B.F. Ascher & Company, Inc., Cadila Pharmaceuticals Ltd., Promius Pharma LLC, Becton, Dickinson and Company, OptiNose Inc., Pfizer Inc., AstraZeneca plc, and GSK plc.